This inventor holds 2 USPTO granted patents. Top assignee: Ranbaxy Laboratories, Inc.. Active years: 2003-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2004
Title: Rajeev S Raghuvanshi: Innovator in Pharmaceutical Formulations
Introduction
Rajeev S Raghuvanshi is a notable inventor based in New Delhi, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled and extended release formulations. With a total of 2 patents to his name, his work has the potential to enhance drug delivery systems.
Latest Patents
Rajeev's latest patents include a controlled release formulation that relates to a pharmaceutical composition comprising amounts ranging from about 0.1 to about 4.5% w/w of one or more rate-controlling cellulosic ether polymers. Additionally, he has developed an extended release formulation of etodolac, which is designed for once-daily administration, showcasing his innovative approach to medication delivery.
Career Highlights
Rajeev S Raghuvanshi is currently associated with Ranbaxy Laboratories, Inc., a prominent player in the pharmaceutical industry. His work at the company has allowed him to focus on advancing drug formulation technologies, contributing to improved patient outcomes.
Collaborations
Rajeev collaborates with Ashok Rampal, leveraging their combined expertise to drive innovation in pharmaceutical formulations.
Conclusion
Rajeev S Raghuvanshi's contributions to pharmaceutical innovations highlight his role as a key inventor in the industry. His patents reflect a commitment to improving drug delivery systems, ultimately benefiting patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile